The objective of the Transgenic Mouse/ES Cell Shared Resource to investigators production is assist in the and use of transgenic and gene knockout mice. Through an interdisciplinary approach, the Resource has been able to provide a broader array of services than are available elsewhere to a large base of investigators. The Shared Resource focuses on quality control, the increased potential for collegial interactions, and immediate access to individuals with deep knowledge of transgenic mice. Experienced personnel develop new procedures and applications, such as those that facilitate the use of site-specific recombinases to perform tissue-specific gene knockouts. As the technology for genome manipulation continues to expand, the Transgenic Mice/ES Cell Shared Resource is likely to grow with it. Specifically, the Shared Resource offers pronuclear DNA microinjection; ES cell microinjection into blastocysts; assisted reproduction; gene targeting; and conditional knockouts utilizing the Cre or FIp(e) site-specific recombinase system; embryo cryopreservation and long-term storage; and sperm cryopreservation and storage. Dr. Cathleen Pettepher is the Director of the Transgenic Mouse/ES Cell Shared Resource and offers consultation to investigators, reviews and approves requests for gene targeting experiments and DNA or ES cell microinjections, and tracks the efficiency and quality of the services offered. She has a highly-trained staff that helps her serve VICC researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-09
Application #
6990171
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-28
Project End
2009-08-31
Budget Start
2004-09-28
Budget End
2005-08-31
Support Year
9
Fiscal Year
2004
Total Cost
$102,068
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Maacha, Selma; Hong, Jun; von Lersner, Ariana et al. (2018) AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking. Neoplasia 20:1008-1022
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Petersen, Christine P; Meyer, Anne R; De Salvo, Carlo et al. (2018) A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut 67:805-817
Wang, Jing; Zhao, Yue; Zhou, Xiaofan et al. (2018) Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation. BMC Genomics 19:633
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233
Davenport, James R; Su, Timothy; Zhao, Zhiguo et al. (2018) Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 67:456-465
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719

Showing the most recent 10 out of 2462 publications